Pricing Log in Create free account

Bolt Biotherapeutics, Inc. (BOLT) vs Radiopharm Theranostics Limited - Sponsored ADR (RADX)

Bolt Biotherapeutics, Inc. and Radiopharm Theranostics Limited - Sponsored ADR are both Biotechnology companies. Radiopharm Theranostics Limited - Sponsored ADR is the larger, with a market value of $14.0M against $12.3M — 1.1× the size. Across the 9 metrics below, Radiopharm Theranostics Limited - Sponsored ADR leads on 7 and Bolt Biotherapeutics, Inc. on 2.

Valuation

Metric BOLT RADX Biotechnology median
P/E n/m — 10.26
P/S 2.35 — 9.18
P/B 0.87 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 2.51 n/m 8.98
Earnings yield (251.76%) — (34.89%)
Free cash flow yield (279.10%) 0.00% (24.52%)

Profitability

Metric BOLT RADX Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (654.53%) — 0.00%
Net margin (611.47%) — 0.00%
Free cash flow margin (655.72%) 0.00% 0.00%
Return on equity (111.65%) 0.00% (50.12%)
Return on assets (49.62%) 0.00% (45.60%)
Return on invested capital (143.75%) 0.00% 0.00%

Growth

Metric BOLT RADX Biotechnology median
Revenue growth (TTM) 12.79% — 6.26%
EPS growth (last fiscal year) 45.91% (1.97%) 29.88%
Revenue growth, 5-year CAGR 101.61% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BOLT RADX Biotechnology median
Debt to equity 1.47 0.00 0.00
Current ratio 2.61 1.16 4.89
Net debt to EBITDA 0.21 0.08 1.01

Dividend

Metric BOLT RADX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BOLT RADX Biotechnology median
Market cap 12.29m 13.96m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack